CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-04 | BHATIA NAVEEN Director | Other acquisition | +500 | 488,599 | ||
| 2024-03-13 | BHATIA NAVEEN Director | Other acquisition | +750 | 488,099 | ||
| 2023-06-14 | BHATIA NAVEEN Director | Grant or award | +225,000 | 487,349 | ||
| 2022-05-18 | BHATIA NAVEEN Director | Purchase | +50,000 | $2.14 | $107K | 246,349 |
| 2021-12-01 | BHATIA NAVEEN Director | Purchase | +50,000 | $4.26 | $213K | 196,349 |
| 2021-11-30 | BHATIA NAVEEN Director | Purchase | +50,000 | $3.88 | $194K | 146,349 |
| 2021-09-15 | BHATIA NAVEEN Director | Option exercise | +96,349 | $1.75 | $169K | 96,349 |
| 2021-09-15 | BHATIA NAVEEN Director | Gift · Warrant (Right to Buy) | +96,349 | 96,349 | ||
| 2021-09-15 | BHATIA NAVEEN Director | Option exercise · Warrant (Right to Buy) | −96,349 | 0 | ||
| 2021-09-08 | BHATIA NAVEEN Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-09-08 | BHATIA NAVEEN Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 |
Page 1 of 1 · 11 trades